Arcus Biosciences SG&A Expense (Quarterly) Analysis

Arcus Biosciences Inc (RCUS)

15.07 +0.14 (+0.94%) USD | NYSE | May 31, 16:00

15.07 0.00 (0.00%) Pre-Market: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	32.00M
December 31, 2023	29.00M
September 30, 2023	30.00M
June 30, 2023	28.00M
March 31, 2023	30.00M
December 31, 2022	28.00M
September 30, 2022	26.00M
June 30, 2022	26.00M
March 31, 2022	24.00M
December 31, 2021	23.01M
September 30, 2021	16.34M
June 30, 2021	16.83M
March 31, 2021	15.82M
December 31, 2020	13.38M
September 30, 2020	11.18M

Date	Value
June 30, 2020	11.43M
March 31, 2020	7.008M
December 31, 2019	6.591M
September 30, 2019	7.758M
June 30, 2019	5.911M
March 31, 2019	4.969M
December 31, 2018	3.61M
September 30, 2018	3.577M
June 30, 2018	3.45M
March 31, 2018	2.929M
December 31, 2017	2.448M
September 30, 2017	1.862M
June 30, 2017	1.83M
March 31, 2017	1.496M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

5.911M

Minimum

Jun 2019

32.00M

Maximum

Mar 2024

19.41M

Average

19.92M

Median

SG&A Expense (Quarterly) Benchmarks